Cite
HARVARD Citation
Pollard, R. et al. (2013). Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren's syndrome: data from a placebo-controlled clinical trial. Annals of the rheumatic diseases. 72 (1), pp. 146-148. [Online].